NeurAxis的IB-Stim设备,用于治疗十几岁的IBS,覆盖510万Molina卫生保健成员。 NeurAxis' IB-Stim device for treating IBS in teens gains coverage for 5.1 million Molina Healthcare members.

NeurAxis是一家医疗技术公司,与Molina Healthcare为其IB-Stim装置投保了保险,涵盖13个州的约510万成员。 NeurAxis, a medical tech company, has secured insurance coverage for its IB-Stim device with Molina Healthcare, covering about 5.1 million members across 13 states. IB-Stim, 林业发展局为治疗8-21岁患有肠道炎综合症(IBS)的青少年腹部功能性疼痛而批准使用,是一种非外科装置,能向耳膜神经提供温和的电子脉冲。 IB-Stim, FDA-cleared for treating functional abdominal pain in adolescents aged 8-21 with irritable bowel syndrome (IBS), is a non-surgical device that delivers gentle electrical impulses to cranial nerves in the ear. 在扩大保险范围之后,IB-Stim的保险范围大幅增加,现在达到5 100万人的生命。 This coverage expansion follows a significant increase in insurance coverage for IB-Stim, now reaching 51 million lives.